Drug Discovery in Neuroscience: Kevin Gorman (Ph.D. ’87, ’91), CEO, Neurocrine Biosciences
Автор: UCLAAnderson
Загружено: 2020-08-12
Просмотров: 1996
Most are hard-pressed to think of a part of the human body more complex than the brain. While many pharmaceutical companies have shied away from the unique challenges neurological disorders present, Neurocrine Biosciences has not. From discovery to development, CEO Kevin Gorman, discusses the company’s journey to treating diseases like Parkinsons and Endometriosis during UCLA Anderson’s VITALS 2020 healthcare conference.
More about Vitals Conference: https://www.anderson.ucla.edu/about/c...
#HealthCare #NeuroScience #PatientCare
Доступные форматы для скачивания:
Скачать видео mp4
-
Информация по загрузке: